Eric Easom 13D and 13G filings for AN2 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-13 4:30 pm Purchase |
2024-12-31 | 13G | AN2 Therapeutics, Inc. ANTX |
Eric Easom | 1,893,132 6.200% |
320,962![]() (+20.42%) |
Filing |
2024-02-13 5:11 pm Purchase |
2022-12-31 | 13G | AN2 Therapeutics, Inc. ANTX |
Eric Easom | 1,572,170 5.200% |
1,572,170![]() (New Position) |
Filing |